MetaCap

iShares Biotechnology ETF (IBB)

NASDAQ: IBBiSharesHealthETFUSD

206.49+6.01 (+3.00%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

IBB chart

Full chart

Key facts

Holdings
10
Inception
Feb 5, 2001
Issuer
iShares
Index tracked
—
Category
Health
52-week range
149.09 – 217.12
Volume / Avg
2.45M / 1.58M
Beta
—
Previous close
200.48

IBB ETF today

The iShares Biotechnology ETF (IBB) is an exchange-traded fund from iShares in the Health category. It charges an expense ratio of 0.44%, or $44.00 per year on a $10,000 investment, and manages $11.20 billion in assets. Its largest holding is Gilead Sciences Inc (GILD) at 8.08% of assets, and the top 10 positions make up 49.3% of the portfolio out of 10 holdings.

The fund's trailing dividend yield is 0.16%. IBB launched on Feb 5, 2001.

Summary generated from market data by MetaCap's automated system. Methodology

IBB top 10 holdings

IBB holdings by weight
#HoldingWeight
1GILDGilead Sciences Inc8.08%
2AMGNAmgen Inc7.78%
3VRTXVertex Pharmaceuticals Inc7.62%
4REGNRegeneron Pharmaceuticals Inc5.28%
5MRNAModerna Inc4.94%
6NTRANatera Inc3.91%
7ARGXargenx SE ADR3.74%
8ILMNIllumina Inc2.89%
9RVMDRevolution Medicines Inc Ordinary Shares2.78%
10BIIBBiogen Inc2.33%

Top 10 holdings: 49.3% of assets.

IBB performance

1 week

+1.55%

IBB price return, excluding dividends.

ETFs similar to IBB

IBB news

All IBB news

IBB ETF FAQ

What is the IBB price today?

IBB last traded at $206.49 as of Oct 9, 4:00 PM EDT, up 3.00% on the day.

What is IBB's expense ratio?

IBB has an expense ratio of 0.44%, which works out to about $44.00 per year for every $10,000 invested.

What are IBB's top holdings?

IBB's largest holdings are Gilead Sciences Inc (8.08%), Amgen Inc (7.78%), Vertex Pharmaceuticals Inc (7.62%), Regeneron Pharmaceuticals Inc (5.28%), Moderna Inc (4.94%). The top 10 make up 49.3% of the fund.

Does IBB pay a dividend?

Yes. IBB has a trailing dividend yield of 0.16%.

How big is IBB?

IBB has about $11.20 billion in assets under management spread across 10 holdings.

Explore